Cleveland Clinic today released research that uses Propeller Health’s smart inhaler platform to show that digital medicines significantly reduced hospital visits for COPD patients. COPD is a term applied to a family of diseases that includes emphysema, chronic bronchitis, and emphysema due to alpha-1 antitrypsin deficiency. The research findings published in The Journal of Telemedicine and Telecare marks the first-ever research to assess the impact of a digital medicine on healthcare utilization
Read More
NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App
NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
Biofourmis Lands $35M for AI-Powered Digital Therapeutics Platform
Biofourmis, a Boston, MA-based digital therapeutics platform, today announced that it has raised $35 million in Series B funding led by Sequoia Capital/Sequoia India and co-led by Mass Mutual. The latest funding round will enable the company to advance its proprietary artificialintelligence (AI)-powered digital therapeutics platform and pipeline that treats and manages a range of complex chronic conditions.Digital Therapeutics is Redefining The Healthcare Value ChainFounded in 2015, Biofourmis
Read More
Solera Health Raises $42M to Scale Integrated Benefit Network for Chronic Disease Prevention
Solera Health, a Phoenix, AZ-based technology-enabled integrated benefit network has raised $42 million in Series C funding led by HCSC Ventures. Current investors BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures also participated in the most recent funding round. The Series C round, Solera's largest to date, brings its total funding to $72 million.Integrated Benefit NetworkFounded in 2015, Solera Health serves as an integrated benefit network
Read More
Fitbit Health Solutions Business Grew 70%, $30.5M in Revenue in Q1 2019
Fitbit today released its Q1 2019 earnings reporting revenue of $272 million, GAAP net loss per share of $(0.31), non-GAAP net loss per share of $(0.15), GAAP net loss of $(79) million, non-GAAP net loss of $(38) million, cash flow from operations of $(68) million and free cash flow of $(74) million.Q1 2019 Fitbit Health Solutions EarningsFitbit Health Solutions business grew 70% YOY with revenue of $30.5M, which was an important contributing factor to the company’s positive momentum overall in
Read More
Validic Integrates With Welldoc’s Bluestar Platform to Enable Real-Time Insights for Patients
Validic, a provider of data solutions for remote monitoring and virtual engagement is integrating with Welldoc’s BlueStar platform. The integration of personal health data within the Welldoc BlueStar digital therapeutic platform will allow users to connect their wearables, apps, and in-home health devices directly to the platform – enabling deeper engagement and better self-management of one's health.The Power of Leveraging Device-Generated Data for PatientsAs the number of people managing
Read More
Israeli-based OurCrowd Launches $50M Medtech Fund
OurCrowd, an Israeli-based global investment platform has announced the launch of the $50 million OurCrowd Medtech Fund. The $50M fund will focus exclusively on investing in disruptive medical technologies and therapeutics with the potential to transform global healthcare delivery and patient outcomes. The announcement marks OurCrowd's first fund dedicated to the medical technology market. OurCrowd vets and selects companies invests its own capital and invites its accredited membership of
Read More
AdoRx Therapeutics, J&J Team Up to Develop Novel Lung Cancer Therapeutics
AdoRx Therapeutics, a UK based drug discovery company, and Johnson & Johnson are teaming up to develop novel therapeutics for the treatment of lung cancer. As part of the strategic collaboration, AdoRx has granted an exclusive option to research, develop and commercialize novel antagonists within the AdoRx portfolio, and the groups will collaborate on drug discovery and preclinical development activities. AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer-based on
Read More
Propeller Health: 84% of People with Asthma May Be Using Their Inhaler Incorrectly
The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose. Recommended Asthma Inhaler GuidelinesAsthma guidelines and patient instructions for inhaled medications recommend that
Read More
Cognoa Awarded FDA Breakthrough Designations for Diagnostic and Digital Therapeutic Devices for Autism
Cognoa, a digital health company focused on behavioral health for children, today announced FDA Breakthrough designations for it's first diagnostic and therapeutic devices to identify and treat autism. This is the foundation for its AI-based digital precision health to support the developmental and behavioral health of children, combining diagnostics and therapeutics into one platform. This signifies a big step in the company’s expansion into therapeutics.FDA Breakthrough Devices Program
Read More